Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCTBiotechnology
+$0.15 today
- Market cap
- $231.73M
- Beta
- 2.35
- P/E (TTM)
- -2.7
- EPS (TTM)
- -$2.77
Volume 0.64M
Average 0.43M
Balance Sheet
Inspect the capital base behind the business.
Assets
$271.15M
FY 2025 · Annual
-21.2% YoYLiabilities
$57.16M
FY 2025 · Annual
-44.6% YoYEquity
$213.99M
FY 2025 · Annual
-11.2% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 370.49M | 391.88M | 292.01M | 237.03M | 230.91M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3.37M | 2.76M | 32.06M | 3.97M | 5.56M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 8.69M | 55M | 64.98M | 4.97M |
| Total Current Assets | 378.96M | 403.33M | 386.59M | 305.98M | 241.45M |
| Property, Plant & Equipment (Net) | 11.26M | 44.96M | 40.93M | 36.21M | 27.82M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 515K | 0 | 1.89M | 0 | 1.89M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.08M | 2.09M | 0 | 1.89M | 0 |
| Total Non-current Assets | 13.85M | 47.05M | 42.81M | 38.09M | 29.7M |
| Total Assets | 392.81M | 450.39M | 429.4M | 344.07M | 271.15M |
| Account Payables | 10.06M | 7.45M | 5.28M | 7.19M | 4.24M |
| Short-term Debt | 22.47M | 60.66M | 0 | 0 | 0 |
| Tax Payables | 0 | 1.3M | 641K | 0 | 0 |
| Deferred Revenue | 43.48M | 36.12M | 47.34M | 21.94M | 8.25M |
| Other Current Liabilities | 3.58M | 4.04M | 18.5M | 13.31M | 6.95M |
| Total Current Liabilities | 99.54M | 126.98M | 81.99M | 65.49M | 36.38M |
| Long-term Debt | 40.63M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 20.07M | 42.5M | 12.6M | 0 |
| Other Non-current Liabilities | 19.93M | 2.8M | 497K | 0 | 0 |
| Total Non-current Liabilities | 65.07M | 53.09M | 68.9M | 37.6M | 20.78M |
| Total Liabilities | 164.6M | 180.08M | 150.89M | 103.09M | 57.16M |
| Common Stock | 26K | 27K | 27K | 27K | 28K |
| Retained Earnings | (347.49M) | (338.14M) | (367.87M) | (448.81M) | (514.59M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 228.21M | 270.31M | 278.51M | 240.98M | 213.99M |
| Total Debt | 69.15M | 94.76M | 30.22M | 28.55M | 25M |
| Net Debt | (301.35M) | (297.13M) | (261.79M) | (208.48M) | (205.91M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $211.4M |
| Receivables | $1.3M |
| Other Current | $4.2M |
| Total Current Assets | $216.9M |
| PP&E (Net) | $26.5M |
| Other Non-current | $2.0M |
| Total Non-current Assets | $28.5M |
| Total Assets | $245.4M |
Analysis
Selected assets total $245.4M for Latest. The largest visible component is Cash & Equivalents at $211.4M, about 86.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 29, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 7, 2026 |
How much cash does ARCT have?
Arcturus Therapeutics Holdings Inc. (ARCT) reported $230.91M in cash and equivalents in fiscal 2025.
How much debt does ARCT carry?
Arcturus Therapeutics Holdings Inc. (ARCT) reported $25.00M of total debt, with net debt of -$205.91M.
Continue the stock analysis
Jump to another research area for this company.